Healthcare -
Biotechnology - NASDAQ - US
$ 0.326
-1.66 %
$ 3.67 M
Market Cap
-0.01
P/E
CYCC - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities CYCC - Cyclacel Pharmaceuticals, Inc.
848 K
LAST VALUE
-80.25%
2 YEAR CAGR
14.60%
5 YEAR CAGR
-29.34%
10 YEAR CAGR